机构:[1]State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangdong Provincial Clinical Research Center for Kidney Disease, Guangdong Provincial Key Laboratory of Nephrology, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China[2]Division of Nephrology, Ruikang Hospital, Guangxi University of Traditional Chinese Medicine, Guangxi Integrated Chinese andWestern Medicine Clinical Research Center for Kidney Disease, Nanning, China[3]Pathology Department, Guangzhou KingMed Center for Clinical Laboratory Co., Ltd, Guangzhou, China[4]Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA[5]Bioland Laboratory (Guangzhou Regenerative Medicine and Health, Guangdong Laboratory), Guangzhou, China
National Key R&DProgram of China,
Grant/Award Number: 2020YFC2005000;
National Natural Science Foundation of China
Grant, Grant/Award Numbers: 82070707, 91949114,
81900627, 82000652; Chinese Postdoctoral Science
Foundation grant, Grant/Award Number:
2020T130277; Guangxi Natural Science Foundation
grant, Grant/Award Number: 2021JJA140160;
Guangxi Administration of Traditional Chinese
Medicine, Grant/Award Number: GZZC2019107;
Chinese andWestern Medicine, Grant/Award
Number: 2019KCXTD014; Frontier Research
Program of Guangzhou Regenerative Medicine
and Health Guangdong Laboratory, Grant/Award
Number: 2018GZR110105004; Outstanding Scholar
Program of Guangzhou Regenerative Medicine
and Health Guangdong Laboratory, Grant/Award
Number: 2018GZR110102004; Outstanding youth
cultivation program in Nanfang Hospital,
Grant/Award Number: 2021J001
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|2 区细胞生物学
最新[2025]版:
大类|1 区医学
小类|2 区细胞生物学
第一作者:
第一作者机构:[1]State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangdong Provincial Clinical Research Center for Kidney Disease, Guangdong Provincial Key Laboratory of Nephrology, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China[2]Division of Nephrology, Ruikang Hospital, Guangxi University of Traditional Chinese Medicine, Guangxi Integrated Chinese andWestern Medicine Clinical Research Center for Kidney Disease, Nanning, China
通讯作者:
通讯机构:[1]State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangdong Provincial Clinical Research Center for Kidney Disease, Guangdong Provincial Key Laboratory of Nephrology, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China[5]Bioland Laboratory (Guangzhou Regenerative Medicine and Health, Guangdong Laboratory), Guangzhou, China[*1]Division of Nephrology, Nanfang Hospital, 1838 North Guangzhou Ave, Guangzhou 510515, China.
推荐引用方式(GB/T 7714):
Chen Shuangqin,Zhang Meijia,Li Jiemei,et al.β-catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN-CD44 axis.[J].Journal of extracellular vesicles.2022,11(3):e12203.doi:10.1002/jev2.12203.
APA:
Chen Shuangqin,Zhang Meijia,Li Jiemei,Huang Jiewu,Zhou Shan...&Zhou Lili.(2022).β-catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN-CD44 axis..Journal of extracellular vesicles,11,(3)
MLA:
Chen Shuangqin,et al."β-catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN-CD44 axis.".Journal of extracellular vesicles 11..3(2022):e12203